| Name |
Administration |
Indication |
| Naglazyme® (galsulfase) |
non-SAI |
Metabolic disorder (Mucopolysaccaroides-IV) |
| Neulasta® (pegfilgrastim) |
SAI |
Neutropenia |
| Neumega® (oprelvekin) |
SAI |
Thrombocytopenia |
| Neupogen® (filgrastim) |
SAI |
Neutropenia |
| Nexavar® (sorafenib) |
oral |
Cancer |
| Norditropin® (somatropin [rDNA origin]) |
SAI |
Growth Stimulant |
| Norditropin/Nordiflex® (somatropin [rDNA origin]) |
SAI |
Growth Stimulant |
| Novantrone® (mitoxantrone HCl) |
non-SAI |
Cancer |
| Novarel® (chorionic gonadotropin) |
non-SAI |
Infertility |
| NovoSeven® /NovoSeven® RT (coagulation
factor VI Ia [recombinant]) |
non-SAI |
Hemophilia |
| Nplate® (romiplostim) |
non-SAI |
Thrombocytopenia |
| Nutropin® (somatropin [rDNA origin]) |
SAI |
Growth Stimulant |
| Nutropin AQ® (somatropin [rDNA origin]) |
SAI |
Growth Stimulant |